Get an industry perspective on the drug development process from Dr. Marty Handfield, a serial entrepreneur and UF Innovate Entrepreneur-in-Residence (EIR). Dr. Handfield has served in product development and leadership roles in a variety of private and public start-up companies.

In this seminar, he will provide an overview of the complex issues in drug development and strategies for startups. Whether you are developing biologics or small molecule therapeutics, join Marty as he shares his insights on navigating the process of bringing new therapeutics to market.

This event is open to the public. Please register by 5PM on Tuesday, January 23. Register here.

Most recently, Martin served as the Chief Scientific Officer (CSO) at Oragenics (NYSE:OGEN) and is currently the Founder, Manager and/or CSO of three local start-ups. He also serves as an Advisory Board Member for the Florida International University Biomolecular Sciences Institute, and he is part of the Dental & Medical Professional Advisory Council for ProBiora Health, a Florida Corporation.